CORDIS
EU research results

CORDIS

English EN

Boosting the Rare Disease research and innovation capacity of the Izmir Biomedicine and Genome Center

Project information

Grant agreement ID: 952346

Status

Grant agreement signed

  • Start date

    1 October 2020

  • End date

    30 September 2026

Funded under:

H2020-EU.4.c.

  • Overall budget:

    € 2 499 125

  • EU contribution

    € 2 499 125

Coordinated by:

IZMIR BIYOTIP VE GENOM MERKEZI

Turkey

Objective

Although diseases afflicting less than 1 person in 2000 are defined as rare diseases, the approx. 6000 different rare diseases together cause, nonetheless, a major burden on human wellbeing and the health systems. Over 90% of all rare diseases are currently without approved treatment and approx. 80% of them are genetic in origin. However, the research on rare diseases and the development of new diagnostic and therapeutic approaches is often hampered by limited resources, including patient material and biological models. The frequency of rare diseases increases in populations with a high frequency of consanguineous marriages. Within ERA, Turkey has the highest rate of consanguineous marriages and, consequently, rare diseases are about twice as prevalent in Turkey than in other ERA countries. The aim of this RareBoost project is to attract an internationally recognized rare disease expert (ERA Chair holder) to the Izmir Biomedicine and Genome Center (IBG), where s/he will lead and direct the new Unit for Rare Diseases and guide its development towards an internationally recognized research facility for rare diseases. IBG is perfectly suited for this development, as it is (i) the largest and best-equipped public biomedical research institute in Turkey, (ii) the only nationally recognized Centre of Excellence in the biomedical sciences, and (iii) already made significant steps towards research excellence. This RareBoost project will greatly facilitate IBG’s aim to become a leading basic and translational research centre for rare diseases. Furthermore, by becoming an internationally recognized hub for rare disease research, IBG will act as a guide for the Turkish R&D sector, will facilitate ERA homogeneity and will support the well-being of rare disease patients. Therefore, RareBoost will greatly boost IBG’s ability to increase ERA-wide cohesion, to support innovation for diagnostics and therapies of certain rare diseases, and to reduce patient suffering.

Coordinator

IZMIR BIYOTIP VE GENOM MERKEZI

Address

Mithatpasa Cad. No:58/5 Balcova
35340 Izmir

Turkey

Activity type

Research Organisations

EU Contribution

€ 2 499 125

Project information

Grant agreement ID: 952346

Status

Grant agreement signed

  • Start date

    1 October 2020

  • End date

    30 September 2026

Funded under:

H2020-EU.4.c.

  • Overall budget:

    € 2 499 125

  • EU contribution

    € 2 499 125

Coordinated by:

IZMIR BIYOTIP VE GENOM MERKEZI

Turkey